这是一篇来自已证抗体库的有关人类 HGAL的综述,是根据4篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合HGAL 抗体。
HGAL 同义词: GCAT2; GCET2; HGAL; germinal center-associated signaling and motility protein; germinal center B-cell-expressed transcript 2 protein; germinal center expressed transcript 2; germinal center-associated lymphoma protein; human germinal center-associated lymphoma

赛默飞世尔
小鼠 单克隆(1H1-A7)
  • 免疫组化-石蜡切片; 人类; 图 1c
赛默飞世尔 HGAL抗体(Thermo Fisher Scientific, 1H1-A7)被用于被用于免疫组化-石蜡切片在人类样品上 (图 1c). Ann Hematol (2017) ncbi
Cell Marque
小鼠 单克隆(MRQ-49)
  • 免疫组化; 人类; 图 1b
Cell Marque HGAL抗体(Cell Marque, MRQ-49)被用于被用于免疫组化在人类样品上 (图 1b). Am J Surg Pathol (2018) ncbi
单克隆(375M-94)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 i1d, i2
Cell Marque HGAL抗体(Cell Marque, MRQ-49)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (图 i1d, i2). Am J Clin Pathol (2017) ncbi
小鼠 单克隆(MRQ-49)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 i1d, i2
Cell Marque HGAL抗体(Cell Marque, MRQ-49)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (图 i1d, i2). Am J Clin Pathol (2017) ncbi
Roche Applied Science
小鼠 单克隆(MRQ-49)
  • 免疫组化-石蜡切片; 人类; 图 1f
Roche Applied Science HGAL抗体(Venatana, MRQ-49)被用于被用于免疫组化-石蜡切片在人类样品上 (图 1f). Histopathology (2017) ncbi
文章列表
  1. Moore E, Swerdlow S, Gibson S. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas. Am J Surg Pathol. 2018;42:342-350 pubmed 出版商
  2. Kunder C, Roncador G, Advani R, Gualco G, Bacchi C, Sabile J, et al. KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas. Am J Clin Pathol. 2017;148:465-476 pubmed 出版商
  3. Shimono J, Miyoshi H, Kamimura T, Eto T, Miyagishima T, Sasaki Y, et al. Clinicopathological features of primary splenic follicular lymphoma. Ann Hematol. 2017;96:2063-2070 pubmed 出版商
  4. Verdanet E, Dereure O, René C, Tempier A, Benammar Hafidi A, Gallo M, et al. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas. Histopathology. 2017;71:648-660 pubmed 出版商